Column

Clinical Pathways GPS

The Future of Medicare…Medicare Managed Care

03/16/2022

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard G Stefanacci, DO, MGH, MBA, explains why it is highly likely that Medicare managed care will represent over half of the Medicare market in the next year and, therefore, become a leader not only for Medicare care but also a guide for...

Richard G Stefanacci, DO, MGH,...

03/16/2022

Journal of Clinical Pathways

Trending From ACCC

Effective Practices in Multidisciplinary Hepatocellular Carcinoma Care

03/16/2022

Association of Community Cancer Centers

Authors from ACCC discuss managing patients with HCC in community cancer programs.

Authors from ACCC discuss...

03/16/2022

Journal of Clinical Pathways

Pharma Insights

The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation

03/16/2022

Cynthia Miller , MD, MPH, FACP;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...

Elizabeth Oyekan, PharmD, FCSHP,...

03/16/2022

Journal of Clinical Pathways

Health Systems Insights

Setting Performance Expectations in Population Health Care Programs

03/16/2022

Joshua M. Liao , MD, MSc, FACP;

Joshua M Liao, MD, MSc suggests ways in which health systems leaders and organizations can calibrate care pathway program performance expectations to better understand true population health care initiative success.

Joshua M Liao, MD, MSc suggests...

03/16/2022

Journal of Clinical Pathways

Trending From ACCC

Registration Opens for the ACCC 48th Annual Meeting and Cancer Center Business Summit

02/16/2022

Association of Community Cancer Centers

Authors from ACCC outline their upcoming 48th Annual Meeting and Cancer Center Business Summit, which will include a panel on how cancer programs and practices are using their data, a keynote titled, "(Over)-Paying for Cancer Care," and more.

Authors from ACCC outline their...

02/16/2022

Journal of Clinical Pathways

Editor's Page

A Call to Action

02/15/2022

Winston Wong , PharmD;

Winston Wong, PharmD, Editor-in-Chief discusses the scope of Journal of Clinical Pathway's growth since its establishment in 2015, calling on a need to also expand the expertise of the Journal's peer reviewers.

Winston Wong, PharmD,...

02/15/2022

Journal of Clinical Pathways

Clinical Pathways GPS

Improving Diabetic Management in Long-term Care

02/15/2022

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard G Stefanacci, DO, MGH, MBA, and colleagues discuss how clinical pathways can improve the Quadruple Aim for the management of diabetes in long-term care.

Richard G Stefanacci, DO, MGH,...

02/15/2022

Journal of Clinical Pathways

Pharma Insights

Bringing Social Determinants of Health to Life to Optimize Health Outcomes in Patients With Chronic Conditions

02/15/2022

Maureen Hennessey , PhD, CPCC, CPHQ;

Jorge Font , MPH;

Cynthia Miller , MD, MPH, FACP;

Dominic Galante , MD, MS, PhD, CPCC;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...

Elizabeth Oyekan, PharmD, FCSHP,...

02/15/2022

Journal of Clinical Pathways

Trending From ACCC

Leveraging Telehealth to Provide Supportive Care to Patients With Metastatic Breast Cancer

12/15/2021

Association of Community Cancer Centers

Patients with metastatic breast cancer facing disparities in care can benefit from telehealth services by saving time and receiving much of their care at home through virtual appointments, patient portal communications, and online education.

Patients with metastatic breast...

12/15/2021

Journal of Clinical Pathways

COA Viewpoint

Don’t Throw Away Community Oncology’s Hard Work: Extend the Oncology Care Model

12/15/2021

Frederick M. Schnell , MD, FACP;

Authors from the Community Oncology Alliance explore what could be next for practices seeking continual improvement in the Oncology Care Model, a multimillion dollar, years-long program that has helped community oncology practices transform...

Authors from the Community...

12/15/2021

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products